Advanced Biotherapy (ADVB) is an undiscovered, research and development company. It has developed treatments for a wide range of autoimmune disorders, including Multiple Sclerosis, Rheumatoid Arthritis, Juvenile Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis. Recently it obtained a Patent Office Notice of Allowance for treatment of asthma and allergies. It has applied for patent protection for an immune system based treatment for acne. The company recently announced that it would commence Phase I testing for HIV patients who have become resistant to conventional treatment.
Once the company's treatments complete the research phase, and pass into the market, I would expect the company to gain substantial recognition and probable share price appreciation.
Steve
